Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives

The non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of chronic liver disease as well as the first cause of liver transplantation. NAFLD is commonly associated with metabolic syndrome (MetS), and this is the most important reason why it is extremely difficult to tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pennisi, Grazia, Celsa, Ciro, Spatola, Federica, Dallio, Marcello, Federico, Alessandro, Petta, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888162/
https://www.ncbi.nlm.nih.gov/pubmed/31703268
http://dx.doi.org/10.3390/ijerph16224334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888162/
https://www.ncbi.nlm.nih.gov/pubmed/31703268
http://dx.doi.org/10.3390/ijerph16224334

Ejemplares similares